Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS J ; 284(11): 1657-1671, 2017 06.
Article in English | MEDLINE | ID: mdl-28425175

ABSTRACT

Snake venom metalloproteases (SVMPs) are members of the a disintegrin and metalloprotease (ADAM) family of proteins, as they possess similar domains. SVMPs are known to elicit snake venom-induced haemorrhage; however, the target proteins and cleavage sites are not known. In this work, we identified a target protein of vascular apoptosis-inducing protein 1 (VAP1), an SVMP, relevant to its ability to induce haemorrhage. VAP1 disrupted cell-cell adhesions by relocating VE-cadherin and γ-catenin from the cell-cell junction to the cytosol, without inducing proteolysis of VE-cadherin. The Wnt receptors low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) are known to promote catenin relocation, and are rendered constitutively active in Wnt signalling by truncation. Thus, we examined whether VAP1 cleaves LRP5/6 to induce catenin relocation. Indeed, we found that VAP1 cleaved the extracellular region of LRP6 and LRP5. This cleavage removes four inhibitory ß-propeller structures, resulting in activation of LRP5/6. Recombinant human ADAM8 and ADAM12 also cleaved LRP6 at the same site. An antibody against a peptide including the LRP6-cleavage site inhibited VAP1-induced VE-cadherin relocation and disruption of cell-cell adhesions in cultured cells, and blocked haemorrhage in mice in vivo. Intriguingly, animals resistant to the effects of haemorrhagic snake venom express variants of LRP5/6 that lack the VAP1-cleavage site, or low-density lipoprotein receptor domain class A domains involved in formation of the constitutively active form. The results validate LRP5/6 as physiological targets of ADAMs. Furthermore, they indicate that SVMP-induced cleavage of LRP5/6 causes disruption of cell-cell adhesion and haemorrhage, potentially opening new avenues for the treatment of snake bites.


Subject(s)
ADAM Proteins/metabolism , Apoptosis Regulatory Proteins/metabolism , Crotalid Venoms/metabolism , Hemorrhage/chemically induced , Low Density Lipoprotein Receptor-Related Protein-5/physiology , Low Density Lipoprotein Receptor-Related Protein-6/physiology , Metalloendopeptidases/metabolism , ADAM Proteins/pharmacology , ADAM12 Protein/metabolism , ADAM12 Protein/pharmacology , Amino Acid Sequence , Animals , Antibodies, Neutralizing/pharmacology , Cell Adhesion/drug effects , Cell Adhesion/physiology , Drug Resistance , Fibrinogen/metabolism , Fibronectins/metabolism , HeLa Cells , Human Umbilical Vein Endothelial Cells , Humans , Hydrophobic and Hydrophilic Interactions , Low Density Lipoprotein Receptor-Related Protein-5/chemistry , Low Density Lipoprotein Receptor-Related Protein-6/chemistry , Male , Membrane Proteins/metabolism , Membrane Proteins/pharmacology , Mice , Models, Molecular , Molecular Docking Simulation , Protein Domains , Protein Structure, Secondary/drug effects , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Species Specificity , Vertebrates/metabolism , Wnt Signaling Pathway/drug effects , Wnt Signaling Pathway/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...